PondRKelemenMD

General Surgery • Dobbs Ferry, NY

Breast, Melanoma, Surgical Oncology (Other than Breast)

Associate Professor, Surgery, Zucker School of Medicine, Hofstra University

Join to view full profile

Dr. Kelemen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kelemen's full profile

Already have an account?

Office
128 Ashford Ave
# Communit
Dobbs Ferry, NY 10522
Phone+1 914-693-5025

Fax+1 914-693-6351

Education & Training

Saint John’s Cancer Institute/Providence Saint John’s Health CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
University of ChicagoResidency, Surgery, 1990 - 1996
University of Illinois College of Medicine at ChicagoResidency, Pathology-Anatomic and Clinical, 1987 - 1990
Stony Brook University Health Sciences Center School of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 2003 - 2026
CA State Medical License 1996 - 1998
IL State Medical License 1986 - 1996
American Board of Surgery Surgery

Awards, Honors, & Recognition

Most Compassionate Doctor American Registry
Fellow (FACS) American College of Surgeons

Clinical Trials

Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer Start of enrollment: 1999 Apr 01
Completed
Phase 3
NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery Start of enrollment: 2012 May 18
Recruiting
Not Applicable
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. Start of enrollment: 2013 Jun 01
Recruiting
Not Applicable
TARGeted Intraoperative radioTherapy (TARGIT) Registry Database Start of enrollment: 2013 Jul 01
Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Start of enrollment: 2017 Apr 28
Recruiting
Extended Follow up of the TARGIT-A Trial Start of enrollment: 2018 Aug 16
Recruiting
Join now to see all

Publications & Presentations

PubMed

Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...
James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01
3 citations
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky
JCO Precision Oncology. 2022-09-01
5 citations
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee
Annals of Surgical Oncology. 2022-04-04

Journal Articles

Development of sentinel lymph node biopsy for melanoma
Pond Kelemen, Facial Plast Surg Clin North Am, 2/2003

Books/Book Chapters

Oxford Textbook of Surgery
Chapter: Lymph Node Diagnosis
Page 2765 - 2767Giuliano AE and Kelemen PROxford Medical publishersEdition 2nd,

Professional Memberships

American College of Surgeons - ACS
Member
American Society of Breast Surgeons - ASBS
Member
American Society of Clinical Oncology - ASCO
Member
Society of Surgical Oncology - SSO
Member

Other Languages

Spanish